137080 — Narae NanoTech Income Statement
0.000.00%
- KR₩36bn
- KR₩91bn
- KR₩40bn
- 27
- 73
- 17
- 30
Annual income statement for Narae NanoTech, fiscal year end - December 31st, KRW millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | PROSPECTUS | ARS | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Revenue | |||||
| Total Revenue | 82,805 | 135,153 | 88,040 | 52,926 | 40,426 |
| Cost of Revenue | |||||
| Gross Profit | 15,184 | 34,731 | 12,369 | -3,281 | -10,708 |
| Selling / General / Administrative Expenses | |||||
| Depreciation and Amortization | |||||
| Unusual Expense / Income | |||||
| Total Operating Expenses | 77,187 | 112,029 | 85,333 | 67,917 | 62,534 |
| Operating Profit | 5,618 | 23,123 | 2,708 | -14,991 | -22,108 |
| Gain / Loss on Sale of Assets | |||||
| Total Net Non Operating Interest Income / Expense | |||||
| Other Net Non Operating Costs | |||||
| Net Income Before Taxes | 2,913 | 22,454 | 2,661 | -16,690 | -21,382 |
| Provision for Income Taxes | |||||
| Net Income After Taxes | 2,233 | 17,472 | 2,522 | -13,283 | -17,141 |
| Net Income Before Extraordinary Items | |||||
| Net Income | 2,233 | 17,472 | 2,522 | -13,283 | -17,141 |
| Income Available to Common Shareholders Excluding Extraordinary Items | |||||
| Income Available to Common Shareholders Including Extraordinary Items | |||||
| Diluted Net Income | 2,233 | 17,472 | 2,522 | -13,283 | -17,141 |
| Diluted Weighted Average Shares | |||||
| Basic EPS Including Extraordinary Items | |||||
| Diluted EPS Including Extraordinary Items | |||||
| Diluted EPS Excluding Extraordinary Items | |||||
| Normalised Income Before Taxes | |||||
| Normalised Income After Taxes | |||||
| Normalised Income Available to Common Shareholders | |||||
| Diluted Normalised EPS | 285 | 2,079 | 152 | -1,201 | -1,552 |
| Dividends per Share |